Oxygen-based therapies have been used on chronic wounds for many years. In a recent article on the 2023 Oxygen and Energy Market, SmartTRAK expressed the view that the Topical Oxygen Therapy Market will grow at a significant rate and that Advanced Oxygen Therapy Inc* is likely to be the biggest driver of that growth. The Company has established a solid evidence base for its TWO2* system, a Topical Wound Oxygen therapy system which applies cyclical pressurized directly to a patient’s wound at home or in a healthcare facility. SmartTRAK talked with the company Medical Director, President and CEO, Dr. Mike Griffiths, about the journey that the company has been on so far, how durable healing and patient-led home care can reduce health inequalities and why the company has recently entered the Negative Pressure Wound Therapy (NPWT) Market.
To find out more about Advanced Oxygen Therapy Inc, click on the following video to listen to the recorded interview (27:56 min). A complete transcript of the interview is available here. For more details, interview topics by timecode are provided below.
Interview Topics by Timecode
00:22 Dr. Griffith’s background and the formation of AOTI
01:46 How TWO2 fits into the treatment pathway
03:34 The differences between oxygen modalities and the evidence base for TWO2
10:34 The impact of durable healing and how stakeholder organizations are adapting to the concept
16:01 The awareness of hypoxia and competing wound care technologies
20:20 Progress within the US and international markets
24:41 AOTI’s entrance into the NPWT market
*These links can only be viewed by SmartTRAK subscribers to this module. For more information on SmartTRAK, including how to receive a demo and subscribe, please click the button below.
To download and read the complete transcript of the "Improving Health Equalities with Durable Healing and Patient-Led Home Care" interview with Dr. Mike Griffiths, CEO, President & Medical Director of Advanced Oxygen Therapy, Inc, just click the button below.